Overview

A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
0
Participant gender:
All
Summary
A Phase 2 study of RTA 402 in Chronic kidney disease (CKD) patients with type 2 diabetes mellitus.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited
Kyowa Kirin Co., Ltd.
Criteria
Inclusion Criteria:

- CKD patients with type 2 diabetes mellitus

- Patients whose eGFR levels are eligible for this study

- Patients being treated with stable dose of ACE inhibitors and/or ARB etc.

Exclusion Criteria:

- Patients with Type 1 diabetes

- Patients with known non-diabetic renal disease

- Patients with a history of renal transplantation

- Patients with mean SBP > 160 mmHg or mean DBP > 90 mmHg

- Patients with HbA1C > 10%

- Patients with cardiovascular disease specified in the study protocol etc.